D. Llobet

发表

Long-term estradiol exposure is a direct mitogen for insulin/EGF-primed endometrial cells and drives PTEN loss-induced hyperplasic growth.

N. Eritja, X. Matías-Guiu, A. Yeramian, 2013, The American journal of pathology.

ERα-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNFα and IL1α in lumen formation and maintenance

N. Eritja, X. Matías-Guiu, G. Masip, 2012, Journal of Cell Science.

Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints

N. Eritja, X. Matías-Guiu, M. Santacana, 2008, Journal of Clinical Pathology.

Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer.

John Calvin Reed, S. Lefebvre, M. Krajewska, 2009, Blood.

Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner

E. Oliva, N. Eritja, X. Matías-Guiu, 2011, Laboratory Investigation.

PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

X. Matías-Guiu, A. Velasco, X. Dolcet, 2006, Human pathology.

A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis.

N. Eritja, X. Matías-Guiu, M. Santacana, 2010, The American journal of pathology.

Survivin Expression in Endometrial Carcinoma:: A Tissue Microarray Study With Correlation With PTEN and STAT-3

M. Rue, X. Matías-Guiu, X. Dolcet, 2005, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells

N. Eritja, X. Matías-Guiu, A. Yeramian, 2008, Oncogene.

Antioxidants block proteasome inhibitor function in endometrial carcinoma cells

N. Eritja, X. Matías-Guiu, A. Yeramian, 2008, Anti-cancer drugs.

Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.

N. Eritja, X. Matías-Guiu, M. Santacana, 2008, Human pathology.

Targeted therapies in gynecologic cancers and melanoma.

X. Matías-Guiu, M. Santacana, A. Yeramian, 2008, Seminars in diagnostic pathology.

Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.

N. Montserrat, X. Matías-Guiu, A. G. de Herreros, 2012, Human pathology.

Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities

M. Rue, X. Matías-Guiu, X. Dolcet, 2005, Modern Pathology.

Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma‐derived cell lines

X. Matías-Guiu, A. Yeramian, A. Sorolla, 2008, The British journal of dermatology.

FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis

M. Rue, X. Matías-Guiu, J. Comella, 2005, Laboratory Investigation.

Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma.

M. Rue, X. Matías-Guiu, X. Dolcet, 2004, The Journal of pathology.

NF-kB in development and progression of human cancer

Xavier Matias-Guiu, X. Matías-Guiu, X. Dolcet, 2005, Virchows Archiv.

Abnormalities in the NF‐κB family and related proteins in endometrial carcinoma

M. Rue, X. Matías-Guiu, X. Dolcet, 2004 .

Lymphocytic Leukemia/Small Lymphocytic Lymphocytes Predisposes to Chronic TNFR-Associated Factor 2 Deficiency in B

John Calvin Reed, J. Zapata, Yongwon Choi, 2014 .

TNFR-Associated Factor 2 Deficiency in B Lymphocytes Predisposes to Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in Mice

John Calvin Reed, J. Zapata, Yongwon Choi, 2012, The Journal of Immunology.

Lymphoma in Mice Lymphocytic Leukemia / Small Lymphocytic Lymphocytes Predisposes to Chronic TNFR-Associated Factor 2 Deficiency in B Pindado

John Calvin Reed, J. Zapata, Yongwon Choi, 2012 .

KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.

Robert E. Lewis, N. Eritja, X. Matías-Guiu, 2011, The American journal of pathology.

Cell Injury , Repair , Aging , and Apoptosis KSR 1 Is Overexpressed in Endometrial Carcinoma and Regulates Proliferation and TRAIL-Induced Apoptosis by Modulating FLIP Levels

Robert E. Lewis, N. Eritja, X. Matías-Guiu, 2011 .

DcR1 expression in endometrial carcinomas

X. Matías-Guiu, M. Santacana, X. Dolcet, 2009, Virchows Archiv.

CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.

N. Eritja, X. Matías-Guiu, M. Santacana, 2009, The American journal of pathology.

Proteasome Inhibitors Induce Death but Activate NF-κB on Endometrial Carcinoma Cell Lines and Primary Culture Explants*

X. Matías-Guiu, J. Comella, X. Dolcet, 2006, Journal of Biological Chemistry.

The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.

N. Eritja, X. Matías-Guiu, M. Santacana, 2010, European journal of cancer.

CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.

N. Eritja, X. Matías-Guiu, M. Santacana, 2009, The American journal of pathology.

A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis.

N. Eritja, A. Yeramian, X. Dolcet, 2010, The American journal of pathology.